Deutsche Bank beats profit expectations in fourth-quarter earnings

Deutsche Bank beats profit expectations in fourth-quarter earnings


Deutsche Bank said Thursday it had record profits during the fourth quarter of 2025.

The German lender’s fourth-quarter results statement showed net profit attributable to shareholders came in at 1.3 billion euros ($1.56 billion) for the three-month period. That beat the 1.12 billion euros forecast by analysts.

Overall, Deutsche Bank’s group revenues came in at 7.73 billion euros for the three-month period ending December, which was in line with an estimae of 7.72 billion euros produced by LSEG.

Meanwhile, its CET 1 capital ratio — which offers a snapshot of bank solvency — was 14.2% for the fourth quarter, down slightly from 14.5% in the previous quarter, and up on 13.8% for the same period in 2024.

Stock Chart IconStock chart icon

hide content

Deutsche Bank.

Elsewhere, credit impairment — a measure of how a loan portfolio is negatively impacted by credit losses — came in at 395 million euros, down on the 408.3 million euros predicted by analysts, and down from 417 million euros in the third quarter.

The fourth-quarter earnings statement comes a day after German federal prosecutors launched a probe into alleged money laundering at the lender, with law enforcement officials searching Deutsche Bank’s offices in Frankfurt and Berlin.

In a statement Wednesday, the bank said it was “cooperating fully” with investigators and declined to comment further.



Source

Jury selection kicks off in Musk v. Altman trial
World

Jury selection kicks off in Musk v. Altman trial

A combination image shows Sam Altman, CEO of OpenAI, during the Asia-Pacific Economic Cooperation (APEC) CEO Summit in San Francisco, California, U.S., on November 16, 2023 and Elon Musk, Chief Executive Officer of SpaceX and Tesla and owner of X, formerly known as Twitter during Viva Technology conference dedicated to innovation and startups at the […]

Read More
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
World

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Pharma thinks it’s found the next frontier in preventing heart attacks.  Novartis, Amgen and Eli Lilly are among the drugmakers betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology. All three of the pharmaceutical giants are in late-stage trials to test whether drugs that cut Lp(a) […]

Read More
Former Google DeepMind researcher’s AI startup raises record .1 billion seed funding to pursue superintelligence
World

Former Google DeepMind researcher’s AI startup raises record $1.1 billion seed funding to pursue superintelligence

A former top researcher at Google AI division DeepMind announced Monday a record $1.1 billion seed round for his months-old startup Ineffable Intelligence. The startup is pursuing superintelligence and was founded in late 2025 by UCL professor and former lead of DeepMind’s reinforcement learning team David Silver. The seed round is the largest ever in […]

Read More